| Dr Michael Samuel Morelli, MD | |
|
8051 South Emerson Ave, Suite 200, Indianapolis, IN 46237-8632 | |
| (317) 865-2955 | |
| (317) 865-2944 |
| Full Name | Dr Michael Samuel Morelli |
|---|---|
| Gender | Male |
| Speciality | Gastroenterology |
| Experience | 27 Years |
| Location | 8051 South Emerson Ave, Indianapolis, Indiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1760489942 | NPI | - | NPPES |
| 200121410 | Medicaid | IN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | 01058426A (Indiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Franciscan Health Indianapolis | Indianapolis, IN | Hospital |
| Schneck Medical Center | Seymour, IN | Hospital |
| Franciscan Health Mooresville | Mooresville, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Indianapolis Gastroenterology Llc | 0244201432 | 17 |
News Archive
Patients with advanced melanoma skin cancer survive for longer without their disease progressing if they have been treated with a combination of two drugs, nivolumab and ipilimumab, than with either of these drugs alone. New results show that these patients also do better regardless of their age, stage of disease and whether or not they have a cancer-driving mutation in the BRAF gene.
A multidisciplinary team of Michigan State University researchers has been awarded $4.2 million to develop accurate clinical research tools for studying osteopathic manipulative medicine, a hands-on approach to the diagnosis and treatment of musculoskeletal disorders.
United BioSource Corporation (UBC) today announced the acquisition of Gigamoto Technology Partners, Inc. (Gigamoto), a Pennsylvania-based software development company providing leading-edge technology solutions in support of drug safety and risk management programs for the life sciences industry.
The American Institute of Ultrasound in Medicine (AIUM) and American Urological Association (AUA) are pleased to announce the collaborative development of the Practice Guideline for the Performance of an Ultrasound Examination in the Practice of Urology.
The British Columbia Court of Appeals this week is hearing a case to decide whether certain sections of Canada's Controlled Drugs and Substances Act that prevent injection drug users from accessing services at the supervised drug-injection facility Insite in Vancouver, British Columbia, are constitutional, Toronto's Globe and Mail reports (Stueck, Globe and Mail, 4/28).
› Verified 1 days ago
| Entity Name | Indianapolis Gastroenterology Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518964493 PECOS PAC ID: 0244201432 Enrollment ID: O20040802001561 |
News Archive
Patients with advanced melanoma skin cancer survive for longer without their disease progressing if they have been treated with a combination of two drugs, nivolumab and ipilimumab, than with either of these drugs alone. New results show that these patients also do better regardless of their age, stage of disease and whether or not they have a cancer-driving mutation in the BRAF gene.
A multidisciplinary team of Michigan State University researchers has been awarded $4.2 million to develop accurate clinical research tools for studying osteopathic manipulative medicine, a hands-on approach to the diagnosis and treatment of musculoskeletal disorders.
United BioSource Corporation (UBC) today announced the acquisition of Gigamoto Technology Partners, Inc. (Gigamoto), a Pennsylvania-based software development company providing leading-edge technology solutions in support of drug safety and risk management programs for the life sciences industry.
The American Institute of Ultrasound in Medicine (AIUM) and American Urological Association (AUA) are pleased to announce the collaborative development of the Practice Guideline for the Performance of an Ultrasound Examination in the Practice of Urology.
The British Columbia Court of Appeals this week is hearing a case to decide whether certain sections of Canada's Controlled Drugs and Substances Act that prevent injection drug users from accessing services at the supervised drug-injection facility Insite in Vancouver, British Columbia, are constitutional, Toronto's Globe and Mail reports (Stueck, Globe and Mail, 4/28).
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michael Samuel Morelli, MD 8051 South Emerson Ave, Suite 200, Indianapolis, IN 46237-8632 Ph: (317) 865-2955 | Dr Michael Samuel Morelli, MD 8051 South Emerson Ave, Suite 200, Indianapolis, IN 46237-8632 Ph: (317) 865-2955 |
News Archive
Patients with advanced melanoma skin cancer survive for longer without their disease progressing if they have been treated with a combination of two drugs, nivolumab and ipilimumab, than with either of these drugs alone. New results show that these patients also do better regardless of their age, stage of disease and whether or not they have a cancer-driving mutation in the BRAF gene.
A multidisciplinary team of Michigan State University researchers has been awarded $4.2 million to develop accurate clinical research tools for studying osteopathic manipulative medicine, a hands-on approach to the diagnosis and treatment of musculoskeletal disorders.
United BioSource Corporation (UBC) today announced the acquisition of Gigamoto Technology Partners, Inc. (Gigamoto), a Pennsylvania-based software development company providing leading-edge technology solutions in support of drug safety and risk management programs for the life sciences industry.
The American Institute of Ultrasound in Medicine (AIUM) and American Urological Association (AUA) are pleased to announce the collaborative development of the Practice Guideline for the Performance of an Ultrasound Examination in the Practice of Urology.
The British Columbia Court of Appeals this week is hearing a case to decide whether certain sections of Canada's Controlled Drugs and Substances Act that prevent injection drug users from accessing services at the supervised drug-injection facility Insite in Vancouver, British Columbia, are constitutional, Toronto's Globe and Mail reports (Stueck, Globe and Mail, 4/28).
› Verified 1 days ago
Irene A Carrothers, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1701 Senate Blvd, Indianapolis, IN 46202 Phone: 317-963-8776 Fax: 317-963-5285 | |
Liam P Howley, MD Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 1001 West 10th St Opw-m200, Indiana University Department Of Medicine, Indianapolis, IN 46202 Phone: 317-630-6560 | |
Cristina Nancy Perez Chumbiauca, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 550 University Blvd, Indianapolis, IN 46202 Phone: 317-944-5000 | |
Dr. Andrew Jonathen Ortega, DO Gastroenterology Medicare: Medicare Enrolled Practice Location: 702 Rotary Cir, Indianapolis, IN 46202 Phone: 317-278-4427 | |
Lawrence John Born, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 8424 Naab Rd, #3-j, Indianapolis, IN 46260 Phone: 317-872-7396 Fax: 317-879-8328 | |
Brian T Robinson, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1001 W 10th St, Indianapolis, IN 46202 Phone: 317-630-7979 Fax: 317-630-2668 | |
Steven T Hugenberg, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 550 University Blvd, Indianapolis, IN 46202 Phone: 317-944-8660 |